Dartmouth Hitchcock Medical Center — Lebanon, New Hampshire

Public research footprint of Dartmouth Hitchcock Medical Center, compiled from the ClinicalTrials.gov public registry.

1,604

Registered studies

442

Active

198

Recruiting now

918

Completed

194

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 · Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma · Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

Recently updated registry entries

NCT03258554 — Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally… (Completed)
NCT06317649 — Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid… (Recruiting)
NCT04267848 — Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Dartmouth Hitchcock Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.